Andrea Pfeifer
Founder bei AC IMMUNE SA
Vermögen: 7 Mio $ am 31.03.2024
Profil
Andrea Pfeifer is the founder of AC Immune SA, where she is currently the Chief Executive Officer & Director since 2016.
She is also the founder of Inventages II.
Dr. Pfeifer's current jobs include being the Chairman of BioMedInvest AG I, Chairman of AB2 Bio SA, Independent Member-Supervisory Board at Symrise AG since 2011, and a Professor at the University of Lausanne.
Her former jobs include being the Chairman of BioMedPartners AG, Member-Supervisory Board at 2invest AG, Principal at Nestlé USA, Inc., and Head-Global Research at Nestlé Nespresso SA. Dr. Pfeifer obtained a doctorate degree from Wuerzburg Schweinfurt University of Applied Sciences.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
AC IMMUNE SA
2,44% | 01.03.2024 | 2 421 226 ( 2,44% ) | 7 Mio $ | 31.03.2024 |
Aktive Positionen von Andrea Pfeifer
| Unternehmen | Position | Beginn |
|---|---|---|
| AC IMMUNE SA | Founder | 13.02.2003 |
| SYMRISE AG | Director/Board Member | 01.05.2011 |
| University of Lausanne | Corporate Officer/Principal | - |
BioMedInvest AG I
 BioMedInvest AG I Investment ManagersFinance BioMedInvest AG I invests in companies located in Switzerland, Germany, Austria, France and Italy. The fund targets companies operating in the fields of drug development, focusing less on diagnostics and medical technology. It acts as lead/co-lead investor and provides financing for start-up to later stage and spin-off capital requirements with an investment size of CHF1 - CHF10 million. | Chairman | - |
AB2 Bio SA
 AB2 Bio SA Pharmaceuticals: MajorHealth Technology AB2 Bio SA develops and manufactures drugs. The firm's products include Interleukin-18 Binding Protein and Proprietary Assay. The company was founded in 2010 and is headquartered in Lausanne, Switzerland. | Chairman | - |
Ehemalige bekannte Positionen von Andrea Pfeifer
| Unternehmen | Position | Ende |
|---|---|---|
| 2INVEST AG | Director/Board Member | 18.10.2012 |
Nestlé Nespresso SA
 Nestlé Nespresso SA Industrial MachineryProducer Manufacturing Nestlé Nespresso SA designs and manufactures espresso machines. The company was founded in 1986 and is headquartered in Zurich, Switzerland. | Corporate Officer/Principal | - |
Inventages II
 Inventages II Investment ManagersFinance Inventages II invests in companies located in Bahamas. The fund focus on companies such as life science and consumer applications. It provides financing for seed, early and buyout capital requirements. | Founder | - |
BioMedPartners AG
 BioMedPartners AG Investment ManagersFinance BioMedPartners AG (BMP), is an independant venture capital firm headquartered in Basel, Switzerland. BMP originated in 2002 as Seed Capital Advisors AG. The firm manages sector-focused venture capital funds including BioMedInvest, BioMedInvest II and BioMedCredit. They specialize in the biomedical sector. | Chairman | - |
| ░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Ausbildung von Andrea Pfeifer
| Wuerzburg Schweinfurt University of Applied Sciences | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| 2INVEST AG | Finance |
| AC IMMUNE SA | Health Technology |
| SYMRISE AG | Process Industries |
| Private Unternehmen | 6 |
|---|---|
Nestlé USA, Inc.
 Nestlé USA, Inc. Agricultural Commodities/MillingProcess Industries Nestle USA, Inc. produces dairy and bakery products. Its products include chocolate and confectionaries, beverages, ice cream, juices, milk products, pet food, prepared foods, and sports nutrition. The company is headquartered in Arlington, VA. | Process Industries |
BioMedInvest AG I
BioMedInvest AG I Investment ManagersFinance BioMedInvest AG I invests in companies located in Switzerland, Germany, Austria, France and Italy. The fund targets companies operating in the fields of drug development, focusing less on diagnostics and medical technology. It acts as lead/co-lead investor and provides financing for start-up to later stage and spin-off capital requirements with an investment size of CHF1 - CHF10 million. | Finance |
Nestlé Nespresso SA
Nestlé Nespresso SA Industrial MachineryProducer Manufacturing Nestlé Nespresso SA designs and manufactures espresso machines. The company was founded in 1986 and is headquartered in Zurich, Switzerland. | Producer Manufacturing |
BioMedPartners AG
BioMedPartners AG Investment ManagersFinance BioMedPartners AG (BMP), is an independant venture capital firm headquartered in Basel, Switzerland. BMP originated in 2002 as Seed Capital Advisors AG. The firm manages sector-focused venture capital funds including BioMedInvest, BioMedInvest II and BioMedCredit. They specialize in the biomedical sector. | Finance |
Inventages II
Inventages II Investment ManagersFinance Inventages II invests in companies located in Bahamas. The fund focus on companies such as life science and consumer applications. It provides financing for seed, early and buyout capital requirements. | Finance |
AB2 Bio SA
AB2 Bio SA Pharmaceuticals: MajorHealth Technology AB2 Bio SA develops and manufactures drugs. The firm's products include Interleukin-18 Binding Protein and Proprietary Assay. The company was founded in 2010 and is headquartered in Lausanne, Switzerland. | Health Technology |
